Source: International Congress 2019 – Tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Chumakova (Stavropol, Russian Federation), R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), V. Odinets (Stavropol, Russian Federation). Markers of thyroid dysfunction in patients with MDR tuberculosis.. 2965

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Hyperuricemia in patients with newly detected MDR tuberculosis. Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Management of tuberculosis in patients with chronic liver dysfunction Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Lipid profile in patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 361s Year: 2002 Treatment‘s side effects in MDR tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005 Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 489s Year: 2005 Hepatic disorders in patients with pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 418s Year: 2005 Diagnosis of COPD in patients with multidrug-resistant tuberculosis Source: International Congress 2018 – COPD around the world Year: 2018 Accompanying therapy of patients with extensive drug-resistant (xdr) lung tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004 The prevalance of tuberculosis in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR) Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004 Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Function of the thyroid gland in patients with tuberculosis Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Outcomes of patients with multidrug resistant tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB) Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007 Reasons for late diagnostics of lung cancer in pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients Source: Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018 Year: 2019